Business Description
Bionano Genomics Inc
NAICS : 334516
SIC : 3841
ISIN : US09075F1075
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.02 | |||||
Equity-to-Asset | 0.56 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -14.83 | |||||
Beneish M-Score | -11.47 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9 | |||||
3-Year EBITDA Growth Rate | -20.7 | |||||
3-Year EPS without NRI Growth Rate | -8.8 | |||||
3-Year FCF Growth Rate | -0.4 | |||||
3-Year Book Growth Rate | 4.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 64.66 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 20.47 | |||||
9-Day RSI | 29.3 | |||||
14-Day RSI | 33.09 | |||||
6-1 Month Momentum % | -70.13 | |||||
12-1 Month Momentum % | -86.75 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.43 | |||||
Quick Ratio | 0.99 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 220.95 | |||||
Days Sales Outstanding | 82.94 | |||||
Days Payable | 114.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -34 | |||||
Shareholder Yield % | -389.23 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -1.8 | |||||
Operating Margin % | -269.62 | |||||
Net Margin % | -407.34 | |||||
FCF Margin % | -279.13 | |||||
ROE % | -158.95 | |||||
ROA % | -88.05 | |||||
ROIC % | -82.72 | |||||
ROC (Joel Greenblatt) % | -311.13 | |||||
ROCE % | -129.74 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.12 | |||||
PB Ratio | 0.37 | |||||
Price-to-Tangible-Book | 0.47 | |||||
EV-to-EBIT | -0.15 | |||||
EV-to-EBITDA | -0.17 | |||||
EV-to-Revenue | 0.6 | |||||
EV-to-Forward-Revenue | 0.43 | |||||
EV-to-FCF | -0.22 | |||||
Price-to-Net-Current-Asset-Value | 2.02 | |||||
Earnings Yield (Greenblatt) % | -666.67 | |||||
FCF Yield % | -452.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BNGO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bionano Genomics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 33.334 | ||
EPS (TTM) ($) | -4.46 | ||
Beta | 2.32 | ||
Volatility % | 62.4 | ||
14-Day RSI | 33.09 | ||
14-Day ATR ($) | 0.021004 | ||
20-Day SMA ($) | 0.23264 | ||
12-1 Month Momentum % | -86.75 | ||
52-Week Range ($) | 0.195 - 2.27 | ||
Shares Outstanding (Mil) | 101.99 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bionano Genomics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bionano Genomics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Bionano Genomics Inc Frequently Asked Questions
What is Bionano Genomics Inc(BNGO)'s stock price today?
When is next earnings date of Bionano Genomics Inc(BNGO)?
Does Bionano Genomics Inc(BNGO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |